glp-1 medication competitors pharmaceutical companies Costs Explained: Managing Coverage Challenges Compound versions of GLP-1 drugs
Description
Prescribing restrictions are likely to relax over time, and coverage and penetration improve, as increased competition and the entry of generics drive price erosion
21, 2024, several generic versions of liraglutide (Victoza) for the treatment of T2DM became commercially available in the U.S
The drugs, typically taken once weekly as injections, work by helping the pancreas increase the production of insulin to move sugar from the blood into body tissues
Pompili M
